Vanderbilt University Medical Center Jul 8 2025 Vanderbilt University Medical Center and Parse Biosciences, an innovator in single-cell sequencing, are collaborating on a new treatment to help unvaccinated measles victims, as the U.S. measles outbreak has now reached its highest case count in 30 years.  While the current MMR vaccine is highly effective in preventing illness from exposure to the mumps, measles, and rubella viruses, the development of injectable monoclonal antibodies that can